TY  - GEN
AU  - Flaherty,Keith T
AU  - Schiller,Joan
AU  - Schuchter,Lynn M
AU  - Liu,Glenn
AU  - Tuveson,David A
AU  - Redlinger,Maryann
AU  - Lathia,Chetan
AU  - Xia,Chenghua
AU  - Petrenciuc,Oana
AU  - Hingorani,Sunil R
AU  - Jacobetz,Michael A
AU  - Van Belle,Patricia A
AU  - Elder,David
AU  - Brose,Marcia S
AU  - Weber,Barbara L
AU  - Albertini,Mark R
AU  - O'Dwyer,Peter J
TI  - A phase I trial of the oral, multikinase inhibitor sorafenib in combination with carboplatin and paclitaxel
SN  - 1078-0432
PY  - 2008///0908
KW  - Administration, Oral
KW  - Adult
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Benzenesulfonates
KW  - administration & dosage
KW  - Biopsy
KW  - Carboplatin
KW  - Female
KW  - Humans
KW  - Male
KW  - Maximum Tolerated Dose
KW  - Middle Aged
KW  - Niacinamide
KW  - analogs & derivatives
KW  - Paclitaxel
KW  - Phenylurea Compounds
KW  - Pyridines
KW  - Sorafenib
KW  - Time Factors
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1158/1078-0432.CCR-07-4123
ER  -